Legal Representation
Attorney
Lisa L. Mueller
USPTO Deadlines
Next Deadline
126 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 26, 2025
Extension Available
Until November 26, 2025
Application History
12 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 29, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 28, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Apr 28, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Apr 28, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 26, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 15, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 15, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Sep 25, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 11, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 11, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 27, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 21, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease
Classification
International Classes
005